Why you can't buy melatonin over the counter in the UK

In an American pharmacy, melatonin sits on the shelf between the vitamins and the fish oil, in gummies, sprays and 10mg tablets. In a British pharmacy it is not on the shelf at all: you need a prescription. Neither country is being careless or paranoid. They have simply answered the same question differently, and the reasoning behind the British answer is worth understanding before you decide how you feel about it.

What is melatonin, and what does it actually do?

Melatonin is a hormone your own brain makes every night. As light fades, the pineal gland releases it, and rising melatonin tells the rest of the body that biological night has begun. It is best understood as a darkness signal rather than a sedative: it does not switch you off the way a sleeping tablet does, it tells your body clock what time it is.

That is also the shape of its evidence. Taken as a supplement, melatonin reliably helps in situations where the clock itself is the problem, such as jet lag and delayed sleep phase, where your internal night is out of step with the one outside [7]. For ordinary difficulty sleeping, the effect is real but modest: a widely cited meta-analysis found it shortened the average time to fall asleep by roughly seven minutes [3]. Useful, honest, and considerably smaller than its reputation.

Two practical details follow from the hormone framing, and both are easy to miss. Timing matters at least as much as quantity: in circadian research, when melatonin is taken relative to your body clock changes how far it shifts the clock, which is not how people use a shelf product they reach for at midnight. And more is not more. The licensed UK preparation contains 2mg in a slow-release form, while supplements abroad commonly carry 5mg or 10mg [2], many times the amount involved in the body's own nightly signal. A hormone used at the wrong time, in amounts the night never intended, can still make you drowsy; what it cannot do is behave like the tidy sleep switch its shelf position suggests.

Why is it prescription-only here?

The UK's medicines framework classifies products largely by what they do to the body, not by what they are made from or how natural they feel. Melatonin is a hormone that acts on human physiology, so it is regulated as a medicine, and in the UK it has been authorised as a prescription-only one [1]. The practical consequences are specific: nobody may sell it to you over the counter, and any licensed product must be manufactured to pharmaceutical standards, in which the dose on the box is the dose in the tablet.

There are licensed melatonin products in the UK. The best known is a 2mg prolonged-release tablet licensed for short-term treatment of insomnia in adults aged 55 and over [2], and there are paediatric preparations prescribed by specialists for particular conditions [1]. So melatonin is present in the British system; it simply arrives with a doctor attached.

The United States drew the line elsewhere. Under its dietary supplement legislation, melatonin is sold as a supplement, which trades tighter assurance for easier access [9]. These are two defensible answers to the same trade-off between access and assurance, and this article is not here to tell you one of them is wrong.

Does the regulation have a point?

One line of evidence is worth knowing when weighing that trade-off. When researchers analysed 31 melatonin supplements bought in ordinary North American shops, the measured content ranged from about 83 percent below the label claim to 478 percent above it, and some products contained serotonin that was not on the label at all [4]. For a hormone whose effect depends on dose and timing, that spread matters. It is the specific problem a medicines licence exists to solve.

None of this makes melatonin dangerous, and none of it makes supplement regulation foolish. It simply explains the British position: a hormone, with meaningful dose-dependence, is handled through the system built for substances like that.

It also explains something a UK reader will sooner or later run into: websites offering to ship melatonin gummies from overseas. We are not going to lecture anyone about that. Those products sit outside the licensing system described above, which means the dose consistency that system exists to guarantee is exactly what you are going without.

What can you do instead?

If sleep has been a struggle for months, the first-line answer in UK guidance is cognitive behavioural therapy for insomnia, and not a substance at all. It is a structured programme that outperforms sleeping tablets in the long run [5]. Your GP can point you to it, and can also consider whether prescribed melatonin is appropriate for you, particularly if you are over 55.

Because melatonin is a darkness signal, you can also strengthen the real one. Bright light soon after waking and dim, warm light in the last hour of the evening push your own melatonin rhythm in the right direction, at a dose no tablet matches. It is unglamorous and it is free.

Among ingredients that may legally be sold over the counter, a few have genuine, if modest, evidence: glycine, an amino acid studied at around three grams before bed for sleep quality and next-day tiredness [6]; L-theanine, studied at around 200mg for winding down without sedation [8]; and magnesium, where the evidence is mixed enough that we have given it an honest article of its own. This evidence base, minus the melatonin, is what Verina's two formulas are built from, and that is all we will say about them here.

References

1. The Human Medicines Regulations 2012 (SI 2012/1916), under which melatonin is classified as a prescription-only medicine in the UK by the MHRA. See also NHS. Melatonin. nhs.uk/medicines/melatonin.
2. Circadin 2 mg prolonged-release tablets: Summary of Product Characteristics. Electronic Medicines Compendium, medicines.org.uk. Indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients aged 55 or over.
3. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS ONE, 2013.
4. Erland LAE, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. Journal of Clinical Sleep Medicine, 2017.
5. National Institute for Health and Care Excellence. Insomnia: Clinical Knowledge Summary, management of long-term insomnia. Cognitive behavioural therapy for insomnia recommended first line. cks.nice.org.uk/topics/insomnia.
6. Yamadera W, et al. Glycine ingestion improves subjective sleep quality in human volunteers. Sleep and Biological Rhythms, 2007.
7. Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database of Systematic Reviews. 2002;(2):CD001520.
8. Hidese S, Ogawa S, Ota M, et al. Effects of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults: a randomized controlled trial. Nutrients. 2019;11(10):2362.
9. Dietary Supplement Health and Education Act of 1994, Public Law 103-417 (United States).